{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:23:49Z","timestamp":1736832229550,"version":"3.33.0"},"posted":{"date-parts":[[2025,1,6]]},"group-title":"In Review","reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,30]]},"abstract":"<title>Abstract<\/title>\n        <p>Primary testicular diffuse large B-cell lymphoma (PT-DLBCL) is a rare and aggressive lymphoma with molecular heterogeneity not well characterize. In this study, we performed next-generation sequencing analysis for a large number of DNA and RNA samples from patients with PT-DLBCL. DNA sequencing analysis identified\u2009\u2265\u20093 chromosomes with copy number variations (CNVs) and microsatellite instability as prognostic biomarkers, rather than <italic>MYD88<\/italic> mutations and genetic subtypes. Remarkably, targeted RNA-seq analysis in 195 patients revealed that <italic>TP53<\/italic> mutations with a\u2009\u2265\u200940% variant allele frequency had significantly adverse prognostic impact, and that a 150-gene expression signature subdivided PT-DLBCL into two distinct clusters, termed as testicular lymphoma tumor (TLT) and microenvironment (ME) subtypes. The TLT subtype featured upregulation of genes involved in B-cell receptor signaling, cell cycle, DNA damage and repair, higher frequencies of CNVs and <italic>MYD88<\/italic> mutations, elder ages, larger tumor sizes, and significantly poorer survival. Genomic microRNA profiling analysis identified significantly differentially expressed microRNAs between 113 PT-DLBCL and 180 systemic DLBCL patients, and further subdivided the PT-DLBCL cohort by microRNA signatures. The subcohort with upregulation of 16 microRNAs associated with PT-DLBCL and testicular tissue expression had significantly better survival. This study revealed characteristic genetic, gene expression, and microRNA profiles and heterogeneity in PT-DLBCL.<\/p>","DOI":"10.21203\/rs.3.rs-5732026\/v1","type":"posted-content","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:45:34Z","timestamp":1736171134000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-8932","authenticated-orcid":false,"given":"Ken","family":"Young","sequence":"first","affiliation":[{"name":"Duke University Medical Center and Duke Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Shi","sequence":"additional","affiliation":[{"name":"Rui Jin hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Xu-Monette","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchao","family":"Jia","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"University Hospital Basel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-8709","authenticated-orcid":false,"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[{"name":"Asan Medical Center, University of Ulsan College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Zhengzhou University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"san raffaele scientific institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongli","family":"Zhai","sequence":"additional","affiliation":[{"name":"Tianjin Cancer Center Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamarija","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[{"name":"National University Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina","family":"Xu","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"University of Verona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-435X","authenticated-orcid":false,"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[{"name":"Aalborg Hospital, Aarhus University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-9352","authenticated-orcid":false,"given":"Henry","family":"Withers","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Long","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Yuan","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Miao","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-4055","authenticated-orcid":false,"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Personalized Cancer Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everardo","family":"Macias","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Shuai","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangchen","family":"Wang","sequence":"additional","affiliation":[{"name":"Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Choi","sequence":"additional","affiliation":[{"name":"Tuen Mun Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marqu\u00e9s de Valdecilla\/IDIVAL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-4371","authenticated-orcid":false,"given":"Weina","family":"Chen","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Han van","family":"Krieken","sequence":"additional","affiliation":[{"name":"Radboud university medical center Nijmegen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-3630","authenticated-orcid":false,"given":"Michael","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Odense University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-2973","authenticated-orcid":false,"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[{"name":"Myeloma Center, University of Arkansas for Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Parsons","sequence":"additional","affiliation":[{"name":"Gundersen Lutheran Health System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hsi","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-4854","authenticated-orcid":false,"given":"Aliyah","family":"Sohani","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Abramson","sequence":"additional","affiliation":[{"name":"Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-6124","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Ferreri","sequence":"additional","affiliation":[{"name":"IRCCS San Raffaele Scientific Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4438","authenticated-orcid":false,"given":"Bing","family":"Xu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-1714","authenticated-orcid":false,"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"16","key":"ref1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164049","article-title":"Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features","volume":"13","author":"Pollari M","year":"2021","unstructured":"Pollari M, Leivonen SK, Lepp\u00e4 S. Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features. Cancers (Basel). 2021;13(16).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.blre.2017.12.001","article-title":"The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies","volume":"32","author":"Twa DDW","year":"2018","unstructured":"Twa DDW, Mottok A, Savage KJ, Steidl C. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. Blood Rev. 2018;32(3):249\u201355.","journal-title":"Blood Rev"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12885-020-6711-0","article-title":"Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China","volume":"20","author":"Chen B","year":"2020","unstructured":"Chen B, Cao DH, Lai L, Guo JB, Chen ZY, Huang Y, et al. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China. BMC Cancer. 2020;20(1):220.","journal-title":"BMC Cancer"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"year":"2024","author":"Roschewski M","key":"ref5","unstructured":"Roschewski M, Phelan JD, Jaffe ES. Primary Large B-cell Lymphomas of Immune-Privileged Sites. Blood. 2024."},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","article-title":"Primary testicular lymphoma","volume":"123","author":"Cheah CY","year":"2014","unstructured":"Cheah CY, Wirth A, Seymour JF. Primary testicular lymphoma. Blood. 2014;123(4):486\u201393.","journal-title":"Blood"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy B","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature medicine. 2018;24(5):679\u201390.","journal-title":"Nature medicine"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright GW","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 2020;37(4):551\u201368 e14.","journal-title":"Cancer Cell"},{"key":"ref9","article-title":"Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas","author":"Autio M","year":"2024","unstructured":"Autio M, Br\u00fcck O, Pollari M, Karjalainen-Lindsberg ML, Beiske K, J\u00f8rgensen JM, et al. Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas. Haematologica. 2024.","journal-title":"Haematologica"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gcc.10234","article-title":"Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas","volume":"38","author":"Kawakami T","year":"2003","unstructured":"Kawakami T, Okamoto K, Kataoka A, Koizumi S, Iwaki H, Sugihara H, et al. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes Chromosomes Cancer. 2003;38(1):97\u2013101.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13148-022-01344-1","article-title":"5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites","volume":"14","author":"Shen Y","year":"2022","unstructured":"Shen Y, Ou J, He B, Yang J, Liu H, Wang L, et al. 5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites. Clin Epigenetics. 2022;14(1):126.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.7150\/ijms.65517","article-title":"Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma","volume":"19","author":"Shen Y","year":"2022","unstructured":"Shen Y, Wang L, Ou J, Wang B, Cen X. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma. Int J Med Sci. 2022;19(2):225\u201332.","journal-title":"Int J Med Sci"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hon.3190","article-title":"Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma","volume":"41","author":"Mansoor A","year":"2023","unstructured":"Mansoor A, Akhter A, Shabani-Rad MT, Deschenes J, Yilmaz A, Trpkov K, et al. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma. Hematol Oncol. 2023;41(5):828\u201337.","journal-title":"Hematol Oncol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/leu.2015.237","article-title":"Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium","volume":"30","author":"Deng L","year":"2016","unstructured":"Deng L, Xu-Monette ZY, Loghavi S, Manyam GC, Xia Y, Visco C, et al. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia. 2016;30(2):361\u201372.","journal-title":"Leukemia"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-21-2949","article-title":"Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC\/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma","volume":"28","author":"Xu-Monette ZY","year":"2022","unstructured":"Xu-Monette ZY, Wei L, Fang X, Au Q, Nunns H, Nagy M, et al. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC\/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2022;28(5):972\u201383.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma","volume":"8","author":"Shen R","year":"2023","unstructured":"Shen R, Fu D, Dong L, Zhang MC, Shi Q, Shi ZY, et al. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8(1):145.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"27","author":"Tzankov A","year":"2014","unstructured":"Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2014;27(7):958\u201371.","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","article-title":"A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL","volume":"4","author":"Xu-Monette ZY","year":"2020","unstructured":"Xu-Monette ZY, Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, et al. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv. 2020;4(14):3391\u2013404.","journal-title":"Blood Adv"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41408-022-00617-5","article-title":"Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms","volume":"12","author":"Albitar M","year":"2022","unstructured":"Albitar M, Zhang H, Goy A, Xu-Monette ZY, Bhagat G, Visco C, et al. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer J. 2022;12(2):25.","journal-title":"Blood Cancer J"},{"issue":"W1","key":"ref20","doi-asserted-by":"crossref","first-page":"W216-W21","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman BT","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic acids research. 2022;50(W1):W216-W21.","journal-title":"Nucleic acids research"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da W","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.0308531101","article-title":"Metagenes and molecular pattern discovery using matrix factorization","volume":"101","author":"Brunet JP","year":"2004","unstructured":"Brunet JP, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A. 2004;101(12):4164\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41408-020-0312-7","article-title":"Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up","volume":"10","author":"Zhou H","year":"2020","unstructured":"Zhou H, Xu-Monette ZY, Xiao L, Strati P, Hagemeister FB, He Y, et al. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer J. 2020;10(5):49.","journal-title":"Blood Cancer J"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love MI","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans CP","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382.","journal-title":"Blood"},{"year":"2024","author":"Aladamat N","key":"ref26","unstructured":"Aladamat N, Tadi P. Histology, Leydig Cells. 2024."},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang D","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: A free online platform for data visualization and graphing. PloS one. 2023;18(11):e0294236.","journal-title":"PloS one"},{"issue":"D1","key":"ref28","doi-asserted-by":"crossref","first-page":"D1055-D61","DOI":"10.1093\/nar\/gkab733","article-title":"DIANA-miTED: a microRNA tissue expression database","volume":"50","author":"Kavakiotis I","year":"2022","unstructured":"Kavakiotis I, Alexiou A, Tastsoglou S, Vlachos IS, Hatzigeorgiou AG. DIANA-miTED: a microRNA tissue expression database. Nucleic acids research. 2022;50(D1):D1055-D61.","journal-title":"Nucleic acids research"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/path.2033","article-title":"Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics","volume":"210","author":"Booman M","year":"2006","unstructured":"Booman M, Douwes J, Glas AM, de Jong D, Schuuring E, Kluin PM. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics. J Pathol. 2006;210(2):163\u201371.","journal-title":"J Pathol"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"1705-16.e5","DOI":"10.1016\/j.ccell.2023.09.004","article-title":"Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial","volume":"41","author":"Zhang MC","year":"2023","unstructured":"Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, et al. Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell. 2023;41(10):1705-16.e5.","journal-title":"Cancer Cell"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.leukres.2012.06.014","article-title":"Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma","volume":"36","author":"Ramirez E","year":"2012","unstructured":"Ramirez E, Singh RR, Kunkalla K, Liu Y, Qu C, Cain C, et al. Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma. Leuk Res. 2012;36(10):1267\u201373.","journal-title":"Leuk Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00432-020-03429-x","article-title":"Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin","volume":"147","author":"Belge G","year":"2021","unstructured":"Belge G, Grobelny F, Radtke A, Bodes J, Matthies C, W\u00fclfing C, et al. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin. J Cancer Res Clin Oncol. 2021;147(2):435\u201343.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11864-018-0555-8","article-title":"Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence","volume":"19","author":"Ollila TA","year":"2018","unstructured":"Ollila TA, Olszewski AJ. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence. Curr Treat Options Oncol. 2018;19(8):38.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091171","article-title":"L-Cysteine Upregulates Testosterone Biosynthesis and Blood-Testis Barrier Genes in Cultured Human Leydig Cells and THP-1 Monocytes and Increases Testosterone Secretion in Human Leydig Cells","volume":"14","author":"Justin Margret J","year":"2024","unstructured":"Justin Margret J, Jain SK. L-Cysteine Upregulates Testosterone Biosynthesis and Blood-Testis Barrier Genes in Cultured Human Leydig Cells and THP-1 Monocytes and Increases Testosterone Secretion in Human Leydig Cells. Biomolecules. 2024;14(9).","journal-title":"Biomolecules"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gendis.2023.02.036","article-title":"The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma","volume":"11","author":"Bian Z","year":"2024","unstructured":"Bian Z, Gu B, Shi G, Guo J, Li D, Zeng H, et al. The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma. Genes Dis. 2024;11(1):80\u20133.","journal-title":"Genes Dis"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3324\/haematol.2018.200105","article-title":"T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma","volume":"104","author":"Leivonen SK","year":"2019","unstructured":"Leivonen SK, Pollari M, Br\u00fcck O, Pellinen T, Autio M, Karjalainen-Lindsberg ML, et al. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma. Haematologica. 2019;104(2):338\u201346.","journal-title":"Haematologica"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3324\/haematol.2018.197194","article-title":"PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma","volume":"103","author":"Pollari M","year":"2018","unstructured":"Pollari M, Br\u00fcck O, Pellinen T, V\u00e4h\u00e4murto P, Karjalainen-Lindsberg ML, Mannisto S, et al. PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma. Haematologica. 2018;103(11):1908\u201314.","journal-title":"Haematologica"},{"key":"ref38","unstructured":"Tale 1. Genes in the primary testicular lymphoma GEP signature, grouped into the 45-gene LTL subsignature and the 105-gene ME subsignature"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5732026\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5732026\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:18:05Z","timestamp":1736781485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5732026\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":38,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5732026\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,1,6]]},"subtype":"preprint"}}